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The mantra of many clinicians when it comes to the inpatient management of infants with acute 
bronchiolitis is “supportive management and hands off”. Recommendations in countries around the 
globe1,2 suggest that the best approach is supportive care alone: support respiratory distress with 
oxygen (stepping up to CPAP or ventilation if needed), support nutrition/fluid balance and wait for 
the natural history of this acute viral infection to take its course, which for the commonest  
pathogen, respiratory syncytial virus is a gradual worsening for 5 days from onset of coryzal 
symptoms then a slow recovery taking about 3 weeks. They all say do not perform chest 
physiotherapy in children with no comorbidities.  Even in France, one country that has 
recommended physiotherapy for bronchiolitis, evidence could not be found for improved symptoms 
or length of stay in a large blinded randomized controlled study using increased exhalation 
technique physiotherapy with assisted cough in just under 500 infants3. 
This year’s Cochrane review included data from 12 studies in 9 countries across three continents, 
concluding that routine physiotherapy for hospitalized infants and children under 2 with 
bronchiolitis could not be recommended because there was a risk of harm and a lack of proven 
benefit.4 In particular the review emphasized that ‘forced expiratory techniques’ in severe 
bronchiolitis could be related to adverse effects such as vomiting, bradycardia with desaturation and 
respiratory destabilization. 
A paper in this month’s journal5 seems to fly in the face of this well-established stance. A large 
blinded randomized trial of physiotherapy in any paediatric respiratory condition is hard to find, but 
one in the acute infant condition of bronchiolitis suggesting we step in and perform airway clearance 
techniques is at odds with common wisdom. However, this study presents evidence for the benefits 
of two different physiotherapy modalities for infants with bronchiolitis at the milder end of the 
spectrum. 
Assisted autogenic drainage (AAD) and intrapulmonary percussive ventilation (IPV, a high frequency 
oscillation delivered in short bursts via a face mask), are known as airway clearance interventions, 
with IPV potentially having some PEEP effects too. Both claim to recruit the smaller airways where 
secretions are thought to cause the obstructive pattern seen in bronchiolitis. They might be 
expected to impact positively on increased mucus production, hyperinflation and atelectasis but 
would not be expected to improve acute inflammation, edema or bronchospasm. The theoretical 
rationale of physiotherapy treatment for acute bronchiolitis in infants, to relieve mucus plugging, 
lung hyperinflation or atelectasis, is credible, but the evidence base has so far failed to materialize. 
This may be due in part to the inflammation, tachypnea, paroxysmal cough and critical airway 
narrowing which usually co-exist in this condition and which are exacerbated by these treatments. 
Physiotherapy for infants with severe bronchiolitis is therefore fraught with balancing clinical benefit 
against the risk of triggering respiratory failure. 
One of the modalities investigated in this study (AAD) arguably has similar characteristics to the 
‘forced expiration techniques’ that attracted concerns in the Cochrane review. During AAD, 
expiratory flow is manipulated by compression over the chest wall, with a view to increasing flow 
velocity. The suggestion from this study is that a modification of this same treatment modality in this 
milder population will result in potentially opposite effects. It is unclear what the mechanism for this 
effect would be, or how to properly advise physiotherapists in future. The two physiotherapists in 
the trial were “well trained”, these are highly specialized physiotherapy techniques and are unlikely 
to be available in the average general paediatric ward setting.  
This month’s paper suggests that these physiotherapy techniques with the help of assisted cough 
and nasopharyngeal rinsing when required, both reduce hospital stays by up to a day. A reduction in 
length of stay (LOS) for this common condition by just a day would have massive implications on 
costs to health services, although there is evidence that LOS is already reducing with just supportive 
care: in the United States a recent study6 showed a mean LOS of 2.4 days compared to studies in the 
early nineties showing 3.3 days.7 The Wang scores in this study were lower than any of those 
described in the Cochrane studies and days to discharge even in the control group of this study, 
equivalent to the lowest of those in the Cochrane studies, suggesting these were mildly affected 
infants. It is unclear how a single daily 20 min treatment would have such a significant effect on   
length of hospital stay unless it is because of the mild nature of the illness in this group. 
Would symptoms so mild justify the time and resources for these treatments? Yes, certainly if the 
time to discharge can reliably be shortened in this way. What is unclear is whether other factors 
were at play. Were Wang scores or discharge decisions reliable? To what extent might the 
nasopharygeal rinsing or tracheal stimulation have influenced results? 
It remains to be seen whether this study is going to turn into another hypertonic saline debate, 
lauded as the first treatment to be effective in bronchiolitis; producing one of the first paediatric 
Cochrane reviews that actually suggested there was enough evidence available to recommend a 
treatment.8 Only later to be shown to have no effect after some further large clinical trials and meta-
analysis,9,10 the original review may have been caught out by the large heterogeneity of many of the 
hypertonic saline trials. 
As the article itself says: more studies are needed, but well done to the research team presenting 
the paper on getting this novel study fully recruited to. Now to the harder part: implementation or 
further studies? Until we know for sure, this study alone should probably not supersede the caution 
recommended by the Cochrane review on physiotherapy4 in this vulnerable patient group. 
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